Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1998 2
1999 2
2000 2
2001 1
2002 2
2003 1
2004 1
2005 2
2006 6
2008 3
2009 4
2010 5
2011 1
2012 3
2013 3
2014 12
2015 6
2016 6
2017 5
2018 3
2019 1
2020 4
2021 4
2022 3
2023 2
2024 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

79 results

Results by year

Filters applied: . Clear all
Page 1
Long-term effects on subclinical cardiovascular disease of switching from boosted protease inhibitors to dolutegravir.
González-Cordón A, Assoumou L, Moyle G, Waters L, Johnson M, Domingo P, Fox J, Stellbrink HJ, Guaraldi G, Masiá M, Gompels M, De Wit S, Florence E, Esser S, Raffi F, Behrens G, Pozniak A, Gatell JM, Martínez E; NEAT 022 Study Group. González-Cordón A, et al. J Antimicrob Chemother. 2023 Sep 5;78(9):2361-2365. doi: 10.1093/jac/dkad247. J Antimicrob Chemother. 2023. PMID: 37539492
Limited Weight Impact After Switching From Boosted Protease Inhibitors to Dolutegravir in Persons With Human Immunodeficiency Virus With High Cardiovascular Risk: A Post Hoc Analysis of the 96-Week NEAT-022 Randomized Trial.
Waters L, Assoumou L, González-Cordón A, Rusconi S, Domingo P, Gompels M, de Wit S, Raffi F, Stephan C, Masiá M, Rockstroh J, Katlama C, Behrens GMN, Moyle G, Johnson M, Fox J, Stellbrink HJ, Guaraldi G, Florence E, Esser S, Gatell JM, Pozniak A, Martínez E; NEAT 022 Study Group. Waters L, et al. Clin Infect Dis. 2023 Mar 4;76(5):861-870. doi: 10.1093/cid/ciac827. Clin Infect Dis. 2023. PMID: 36259527 Clinical Trial.
Accentuated aging associated with HIV in a Mediterranean setting occurs mainly in persons aged>70 years: a comparative cohort study (Over50 cohort).
Negredo E, Loste C, Puig J, Echeverría P, Fumaz CR, Muñoz-Moreno JA, Lemos B, Martínez A, Tamayo F, Saiz M, Estany C, Matarrodona M, Bonjoch A, Blanco N, Satorra P, Clotet B. Negredo E, et al. Among authors: bonjoch a. AIDS Care. 2022 Feb;34(2):155-162. doi: 10.1080/09540121.2021.1998314. Epub 2021 Nov 7. AIDS Care. 2022. PMID: 34743624
Management of bone mineral density in HIV-infected patients.
Negredo E, Bonjoch A, Clotet B. Negredo E, et al. Among authors: bonjoch a. Expert Opin Pharmacother. 2016;17(6):845-52. doi: 10.1517/14656566.2016.1146690. Epub 2016 Feb 15. Expert Opin Pharmacother. 2016. PMID: 26809940 Review.
A randomized pilot trial to evaluate the benefit of the concomitant use of atorvastatin and Raltegravir on immunological markers in protease-inhibitor-treated subjects living with HIV.
Negredo E, Jiménez M, Puig J, Loste C, Pérez-Álvarez N, Urrea V, Echeverría P, Bonjoch A, Clotet B, Blanco J. Negredo E, et al. Among authors: bonjoch a. PLoS One. 2020 Sep 17;15(9):e0238575. doi: 10.1371/journal.pone.0238575. eCollection 2020. PLoS One. 2020. PMID: 32941476 Free PMC article. Clinical Trial.
79 results